A Chinese pharmaceutical group developing and manufacturing innovative and generic medicines, across four R&D bases in Jiangsu, Shanghai and Beijing.
Yangtze River Pharmaceutical Group
Released August 11, 2026
Antibody language model fine-tuned to predict hydrophobic interaction chromatography retention from paired heavy and light chain sequence alone.